B
TENX icon

Bailard’s Tenax Therapeutics TENX Stock Holding History

Bailard’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-2
Closed -$197K – 346
2015
Q4 		$197K Buy
+2
New +$207K 0.09% 193

Other funds holding TENX

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bailard's TENX Position: Q1 2016 in Review

Bailard sold out of Tenax Therapeutics (TENX) in Q1 2016, closing a stake of 2 shares — an estimated $197K sold.

Bailard first reported a position in TENX in Q4 2015 and held it in 1 quarter. The position peaked at $197K in Q4 2015. 23 funds tracked by Wall St. Rank hold TENX as of Q1 2016.

  • Bailard reported no remaining Tenax Therapeutics position as of Q1 2016 after selling out during the quarter.
  • Bailard sold 2 Tenax Therapeutics shares in Q1 2016, an estimated $197K.
  • Bailard first reported a position in Tenax Therapeutics in Q4 2015 and held it in 1 quarter.
  • Bailard's Tenax Therapeutics position peaked at $197K in Q4 2015.
  • 23 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q1 2016.

Based on Bailard's 13F filing for Q1 2016, filed 16 May 2016.